Evidence map›Paper›PMID 37082268›Full record

ArticleBBA advances2023

Mapping glycation and glycoxidation sites in collagen I of human cortical bone.

Paul Voziyan, Sasidhar Uppuganti, Micheal Leser, Kristie L Rose, Jeffry S Nyman

Open access · goldAbstract read
In one paragraph

Article in BBA advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Pentosidine as a biomarker for bone fragility: Molecular mechanisms, clinical relevance, and detection strategies.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Paul VoziyanDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Sasidhar UppugantiDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Micheal LeserDepartment of Biochemistry and Proteomics Core, Mass Spectrometry Research Center, Vanderbilt University, Nashville, TN 37232, United States.
Kristie L RoseDepartment of Biochemistry and Proteomics Core, Mass Spectrometry Research Center, Vanderbilt University, Nashville, TN 37232, United States.
Jeffry S NymanDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Vanderbilt University · USVanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

The Roles of Collagen and Water in the Fracture Resistance of BoneR01AR063157 · NIAMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NYMAN, JEFFRY STEPHEN · 2012 to 2025
$3.9M
Diabetes-Related Changes Affecting Bone QualityI01BX004297 · VA · VETERANS HEALTH ADMINISTRATION · PI NYMAN, JEFFRY STEPHEN · 2019 to 2023
–
BLRD VA I01 BX004297NIAMS NIH HHS R01 AR063157
6 · The paper itself

Abstract

Accumulation of advanced glycation end products (AGEs), particularly in long-lived extracellular matrix proteins, has been implicated in pathogenesis of diabetic complications and in aging. Knowledge about specific locations of AGEs and their precursors within protein primary structure is critical for understanding their physiological and pathophysiological impact. However, the information on specific AGE sites is lacking. Here, we identified sequence positions of four major AGEs, carboxymethyllysine, carboxyethyllysine, 5-hydro-5-methyl imidazolone, and 5-hydro-imidazolone, and an AGE precursor fructosyllysine within the triple helical region of collagen I from cortical bone of human femurs. The presented map provides a basis for site-specific quantitation of AGEs and other non-enzymatic post-translational modifications and identification of those sites affected by aging, diabetes, and other diseases such as osteoporosis; it can also help in guiding future studies of AGE impact on structure and function of collagen I in bone.

Indexed as

Advanced glycation end-productCollagen type IDiabetesHuman boneMass spectrometryPost-translational modification mapping

Identifiers

PMID37082268
PMCPMC10074956
OpenAlexW4317702618

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.